Abbott Labs shares pop as revenue, earnings defy steep drop in Covid test sales

[ad_1] The Abbott manufacturing facility in Sturgis, Michigan, on May 13, 2022. Jeff Kowalsky | AFP | Getty Images Shares of Abbott Laboratories popped Wednesday after the company’s earnings and revenue topped Wall Street’s expectations, defying a dramatic slowdown in sales of its Covid-19 tests.  The medical-products company posted adjusted earnings per share of $1.03….

Read More

Johnson & Johnson shares fall after company beats on earnings and revenue, but lowers pharmaceutical sales guidance

[ad_1] Johnson & Johnson shares fell Tuesday after the company reported adjusted earnings and revenue that topped Wall Street’s expectations, but lowered its sales guidance for its pharmaceutical business. J&J, whose financial results are considered a bellwether for many health companies, said its sales during the quarter grew 5.6% over the same quarter last year.  related…

Read More